Astex Therapeutics Ltd v Astrazeneca AB [2017] EWHC 1442 (Ch), [2017] All ER (D) 118 (Jun)
The Chancery Division made rulings in a dispute over a contract between the parties to develop compounds for the treatment of Alzheimer’s Disease. Among other things, it held that neither of the compounds created were ‘collaboration compounds’ within the meaning of the contract, so that the claimant company was not able to claim royalties on them.
From global fraud cases to fishing off-grid, Mishcon de Reya’s chair of dispute resolution Hugo Plowman discusses mentors, management switching off
Maguire Family Law announces partner promotion and new hires amid a record year for enquiries
Switalskis wills and probate team extends reach with two appointments
